dipyrone has been researched along with Hematologic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaser, LS; Egger, P; Haschke, M; Krähenbühl, S; Rätz Bravo, AE; Tramonti, A | 1 |
| Hedenmalm, K; Spigset, O | 1 |
| KHAVEZOV, K; SHISHMANOV, N | 1 |
3 other study(ies) available for dipyrone and Hematologic Diseases
| Article | Year |
|---|---|
Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dipyrone; Female; Hematologic Diseases; Humans; Infant; Male; Middle Aged; Switzerland; World Health Organization; Young Adult | 2015 |
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Female; Hematologic Diseases; Humans; Male; Middle Aged; Risk Factors; Sweden | 2002 |
[Sulfohemoglobin intoxication in simultaneous therapy with analgin and magnesium sulfate].
Topics: Aminopyrine; Diabetes Complications; Dipyrone; Female; Hematologic Diseases; Humans; Magnesium Sulfate; Neuritis; Pregnancy | 1957 |